Recently, the Food and Drug Administration (FDA) approved the supplemental New Drug Application for Trelegy Ellipta® for the maintenance treatment of asthma in patients aged 18 years and older. This new indication is in addition to Trelegy Ellipta®’s previous indication for the maintenance treatment of chronic obstructive pulmonary disease (COPD) in adults. This new indication, …
Update: FDA now recommends prescribing naloxone and requires new labeling changes for opioids In its Drug Safety Communication from July 23, 2020, the Food and Drug Administration (FDA) has announced that it recommends that health care professionals consider prescribing naloxone to patients at increased risk of opioid overdose, including those taking benzodiazepines or other CNS …
With over 30 years’ experience as a pharmacist, dental educator and author, Tom Viola, R.Ph. has earned his reputation as the go-to specialist for delivering quality dental continuing education content through his informative, fun and engaging dental pharmacology presentations.
Copyright © 2021 Thomas A. Viola, R.Ph., C.C.P. Pharmacology Declassified. All Rights Reserved.
